Global  

“News neutrality by unbiased coverage”
One News Page
> >

Gilead to Present Wide-Ranging New Data on Treatment and Diagnosis of Liver Diseases at The Liver Meeting® 2018

Business Wire Thursday, 11 October 2018
Gilead to Present Wide-Ranging New Data on Treatment and Diagnosis of Liver Diseases at The Liver Meeting® 2018FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that data from the company’s liver disease research and development programs in nonalcoholic steatohepatitis (NASH), primary sclerosing cholangitis (PSC), hepatitis B virus (HBV) infection and hepatitis C virus (HCV) infection will be presented at The Liver Meeting® 2018 in San Francisco from November 9-13, 2018. The data reflect Gilead’s ongoing commitment to advancing the care of patients with serious l
0
shares
ShareTweetSavePostSend
 

Recent related news from verified sources

Immune Pharmaceuticals Announces Adjournment of Special Meeting of Stockholders

Meeting adjourned in order to gather additional votes FORT LEE, N.J., Dec. 06, 2018 (GLOBE NEWSWIRE) -- Immune Pharmaceuticals, Inc. (*OTCQB; IMNP*)...
GlobeNewswire - Press ReleasesAlso reported by •Proactive Investors

National Institute on Drug Abuse Presents Data on Trevena’s TRV734 at the 57th Annual Meeting of the American College of Neuropsychopharmacology

CHESTERBROOK, Pa., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ: TRVN), a biopharmaceutical company focused on the development and commercialization...
GlobeNewswire - Press Releases

Open Science and Data Initiative Announced for Neurofibromatosis by the Children's Tumor Foundation

Major Research Funders Join Together to Advance Research into Genetic Disorder NEW YORK (PRWEB) December 14, 2018 The Children’s Tumor Foundation (CTF),...
PRWeb - Press Releases

Stemline Therapeutics Recaps Key Clinical Data Presentations from the American Society of Hematology (ASH) Annual Meeting

NEW YORK, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML), a biopharmaceutical company focused on the development and potential...
GlobeNewswire - Press Releases

You Might Like


Tweets about this


Other recent news in Press Releases

SOMiC Offers Holiday Discounts on 5 Headphones, Making Them the Perfect CHRISTMAS GiftsVantagepoint ai Trading SOFTWARE Expands Global Partnership to Italy
Saudi Arabia $179 MILLION Oil & Gas Drilling Tools Market, Competition Forecast & Opportunities, 2023Bragar Eagel & Squire, P.C. is Investigating JOHNSON & JOHNSON (JNJ) on Behalf of Stockholders and Encourages JNJ Investors to Contact the Firm
Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2018 One News Page Ltd. All Rights Reserved.
About us  |  Contact us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Contact us  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter  •  FOLLOW us on Pinterest